156 related articles for article (PubMed ID: 12183430)
21. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
22. [Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials].
Li Y; Tang Z; Ye S; Liu B; Liu Y; Chen J; Xue Q
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):533-6. PubMed ID: 12667318
[TBL] [Abstract][Full Text] [Related]
23. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
24. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
28. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
29. Brain metastasis from hepatocellular carcinoma associated with hepatitis B virus.
Frati A; Salvati M; Giarnieri E; Santoro A; Rocchi G; Frati L
J Exp Clin Cancer Res; 2002 Sep; 21(3):321-7. PubMed ID: 12385572
[TBL] [Abstract][Full Text] [Related]
30. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
[TBL] [Abstract][Full Text] [Related]
31. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
32. Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.
Kotaka M; Chen GG; Lai PB; Lau WY; Chan PK; Leung TW; Li AK
Oncol Res; 2002; 13(3):161-7. PubMed ID: 12549625
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization.
Wilkens L; Bredt M; Flemming P; Klempnauer J; Heinrich Kreipe H
J Pathol; 2000 Sep; 192(1):43-51. PubMed ID: 10951399
[TBL] [Abstract][Full Text] [Related]
34. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
[TBL] [Abstract][Full Text] [Related]
35. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
[TBL] [Abstract][Full Text] [Related]
37. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
[TBL] [Abstract][Full Text] [Related]
38. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
39. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
[TBL] [Abstract][Full Text] [Related]
40. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]